Minnesota-based medtech giant St. Jude Medical (NYSE:STJ) is broaching new ground in the spinal pain market with the $200 million acquisition of NeuroTherm, maker of radiofrequency ablation therapies.
Neuromodulation/Neurostimulation
FDA flags Zynex Medical over chronic pain devices
NeuroMetrix wins FDA nod for over-the-counter chronic pain device
Headache devices avoid heavy regulation in new FDA rule
The FDA agreed to downgrade headache treatment devices to a lower-risk classification, allowing new devices to reach the U.S. market with less-stringent oversight.
The devices went from Class III controls for high-risk devices, requiring premarket approval, to Class II controls for moderate-risk devices, reviewed through the fast-track 510(k) review pathway.
InSightec seeks $50M for ultrasound tumor therapy
Israel-based InSightec is looking for a few investors to jump in on its $50 million Series D funding round, saying it’ll use the funds to boost commercial efforts for its non-invasive tumor-targeting ultrasound therapy.
York Capital Management is already lined up to take a chunk out of the $50 million, leaving "limited time" for other prospective funders to jump in on the initial round or to expand fundraising to $62.5 million, InSightec said.
Breakthrough tech lets paraplegic man move hand with only his thoughts
Researchers touted a major breakthrough this week when a paraplegic patients successfully moved his own hand using only signals from his own mind.
The technology is comprised of a microchip implanted in the brain and a "sleeve" laden with electrodes that stimulates the muscles in the arm in precise coordination with signals from the brain. Unlike other technologies that rely on robotics or computers to move paralyzed limbs, the so-called "NeuroBridge" system translates brain signals into muscle stimulation.
Supreme Court refuses to hear Medtronic’s pain pump lawsuit appeal
The Supreme Court today refused to hear Medtronic’s (NYSE:MDT) request for review in a lawsuit accusing the company of negligence and liability over its implantable pain pumps.
Cervel Neurotech raises $11M for device-based depression therapy
California-based medical device maker Cervel Neurotech is nearing the close of an $11.9 million funding round, having raised $11.1 million since April 2013 in support of its technology-based therapies for neurological and psychiatric disorders.
Mass. General gets $30M DoD grant to build brain implant for mental illness | MassDevice.com On Call
MASSDEVICE ON CALL — Researchers at Massachusetts General Hospital were recipients of a $30 million grant to build brain implants for treating mental illness, targeting combat veterans coming home with brain injuries, depression and post-traumatic stress disorder.
Medtronic slips ‘death penalty’ sanctions in pain pump death suit
FDA OKs eNeura’s mobile migraine treatment device
Maryland medical device maker eNeura today touted FDA clearance for its SpringTMS system, a mobile magnetic stimulator that can help relieve pain associated with migraines that are preceded by an ‘aura.’